CSI Market
Sign In | Register

Meridian Bioscience Inc (VIVO) Annual Income Statement

Annual · GAAP · USD millions
Access VIVO quarterly income statements →
This page allows investors to track Meridian Bioscience Inc's income statement performance across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Sep 30 2022)
2022 		(Sep 30 2021) (Sep 30 2020) (Sep 30 2019) (Sep 30 2018)
Revenues
Total Revenue333.02
Costs & Expenses
Cost of Goods and Services Sold144.66
Gross Profit188.36
Selling, Administration, Marketing31.27
Research and Development Expense24.34
Business Combination, Acquisition Related Costs8.05
Other Operating Expense / -Income57.15
Legal Fees0.00
Total operating costs including COS278.63
Operating income / -loss54.39
Interest Expense1.19
Net Interest Expense / -Income1.19
Investment Income, Interest-0.02
Other loss / -income-1.10
Total costs & expenses278.70
Income & Taxes
Income / -loss before income taxes54.32
Income taxes expenses / -benefit11.86
Income after income taxes42.46
Net income / -loss of other equity0.00
Income / -loss from continuing operations42.46
Net income / -loss42.46
Income / -loss to shareholder42.46
EBIT55.51
EBITD62.05
EBITDA72.02
Earnings Per Share
Basic EPS (excl. extra items)0.97
Basic Net EPS0.97
Basic shares outstanding (Mill. of Units)43.58
Diluted Net EPS0.96
Diluted average shares (Mill. of Units)44.38
Dividend per share0.00
4 historic quarters locked

Sign in to unlock the full Meridian Bioscience Inc income statement history.

Sign In Create Free Account

About VIVO Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.